This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Brand Names
- Afluria Tetra, Agriflu, FluLaval Tetra, Fluad, Fluad Pediatric, Fluviral, Fluzone High-Dose Quadrivalent, Fluzone Quadrivalent, Influvac Tetra
- Generic Name
- Haemagglutinin-strain A(H1N1)
- DrugBank Accession Number
- DB15476
- Background
Not Available
- Type
- Biotech
- Groups
- Approved
- Biologic Classification
- Vaccines
Inactivated - Synonyms
- Haemagglutinin-strain A (H1N1)
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Brand Name Prescription Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Panenza Suspension 15 mcg / 0.5 mL Intramuscular Sanofi Pasteur Limited Not applicable Not applicable Canada 
- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image ADIMFLU Haemagglutinin-strain A(H1N1) (15 mcg/0.5ml) + Haemagglutinin-strain A(H3N2) (15 mcg/0.5ml) + Influenza virus type B (Victoria) (15 mcg/0.5ml) บริษัท ไบโอเนท - เอเชีย จำกัด จำกัด 2019-09-09 Not applicable Thailand 
Afluria Tetra Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Victoria-like) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata-like) (15 mcg / 0.5 mL) Suspension Intramuscular Seqirus Pty Ltd 2020-09-23 Not applicable Canada Afluria Tetra Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Victoria-like) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (Yamagata-like) (15 mcg / 0.5 mL) Suspension Intramuscular Seqirus Pty Ltd 2019-10-25 Not applicable Canada Afluria Tetra Injektionssuspension in einer Fertigspritze Haemagglutinin-strain A(H1N1) (15 mcg) + Haemagglutinin-strain A(H3N2) (15 mcg) + Haemagglutinin-strain B (Victoria-like) (15 mcg) + Influenza B virus B/Phuket/3073/2013 BVR-1B antigen (formaldehyde inactivated) (15 mcg) Injection, suspension Intramuscular Seqirus Netherlands B.V. 2020-05-26 Not applicable Austria 
Agriflu Haemagglutinin-strain A(H1N1) (15 mcg / 0.5 mL) + Haemagglutinin-strain A(H3N2) (15 mcg / 0.5 mL) + Haemagglutinin-strain B (15 mcg / 0.5 mL) Suspension Intramuscular Seqirus Uk Limited 2015-10-09 Not applicable Canada
Categories
- Drug Categories
- Not Available
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
- Not Available
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 4 Active Not Recruiting Prevention Adverse Reaction to Vaccine / Elderly Infection / Flu caused by Influenza / Obesity / Pregnancy; Infection / Tolerance / Vaccine Reaction 1 4 Completed Basic Science Flu caused by Influenza 2 4 Completed Basic Science Flu caused by Influenza / Human Immunodeficiency Virus (HIV) Infections 1 4 Completed Basic Science Flu caused by Influenza / Human Immunodeficiency Virus (HIV) Infections / Tuberculosis (TB) 1 4 Completed Health Services Research Flu caused by Influenza / Vaccination Site Reactions (HT) 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Injection, suspension Intramuscular Suspension Intramuscular Suspension Intramuscular; Subcutaneous Injection, suspension Intramuscular; Subcutaneous Suspension Intradermal Suspension Intramuscular 15 mcg / 0.5 mL Injection - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
Drug created at August 30, 2019 15:26 / Updated at November 30, 2021 07:50